- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00858494
Homeopathic Cold Medicine for Children
July 23, 2018 updated by: James Taylor, University of Washington
The purpose of this study is to determine if a commercially available homeopathic cold remedy for children is effective in providing relief from cold symptoms in children 2-5 years old.
It is postulated that children will have relief of symptoms after receiving a dose of the cold remedy
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98105
- University of Washington Medical Center-Roosevelt Pediatric Care Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 1 year (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Children 24-59 months old
- Cold/cough symptoms of <7 days duration
- Diagnosed with upper respiratory tract infection by physician or nurse practitioner
- Parent who speaks and reads English
Exclusion Criteria:
- Use of chronic medication other than multivitamins
- History of asthma
- Medication other than acetaminophen or ibuprofen
- Use of homeopathic remedy within preceding 30 days
- Only 1 participant per family
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: homeopathic cold remedy
|
Liquid homeopathic cold remedy, 5 ml by mouth every 4 hours as needed for relief of cold symptoms for up to 10 days
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Relief of Upper Respiratory Tract Infection (URI) Symptoms (Cough, Runny Nose, Nasal Congestion, Sneezing)1 Hour After Dose of Homeopathic Remedy.
Time Frame: up to 10 days from index visit
|
For each dose of study medication, parents indicated which of the symptoms were present (runny nose, cough, nasal congestion, sneezing).
Parents rated change in each symptom present one hour after a dose of study medication for up to 6 doses in study logs.
Responses were dichotomized as at least some improvement or better (improvement) vs. no improvement or worse.
The outcome measure is number of times that improvement in a specific symptom was noted after a dose of the homeopathic remedy.
Completed study logs were received from 37 of 49 enrolled participants.
|
up to 10 days from index visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Parental Report of an Adverse Event After a Dose of Study Medication
Time Frame: data collected after doses occurring up to 10 days after index visit
|
After each dose of study medication parents reported the presence of any adverse events
|
data collected after doses occurring up to 10 days after index visit
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2009
Primary Completion (Actual)
October 1, 2009
Study Completion (Actual)
October 1, 2009
Study Registration Dates
First Submitted
March 5, 2009
First Submitted That Met QC Criteria
March 6, 2009
First Posted (Estimate)
March 9, 2009
Study Record Updates
Last Update Posted (Actual)
July 26, 2018
Last Update Submitted That Met QC Criteria
July 23, 2018
Last Verified
July 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 35537
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Upper Respiratory Tract Infection
-
NovartisNovartis Consumer HealthCompleted
-
Daewon Pharmaceutical Co., Ltd.CompletedFever | Acute Upper Respiratory InfectionKorea, Republic of
-
China Academy of Chinese Medical SciencesGuangdong Provincial Hospital of Traditional Chinese Medicine; Guang'anmen... and other collaboratorsUnknownAcute Upper Respiratory InfectionChina
-
Penn State UniversityUniversity of GhanaNot yet recruitingUpper Resp Tract InfectionGhana
-
Guangzhou Yipinhong Pharmaceutical CO.,LTDCompletedAcute Upper Respiratory InfectionChina
-
Bioithas SLCentro Sperimentale del Latte S.r.l.RecruitingPrevention | Upper Respiratory Tract InfectionSpain
-
Guangzhou Yipinhong Pharmaceutical CO.,LTDCompletedAcute Upper Respiratory InfectionChina
-
Société des Produits Nestlé (SPN)Completed
-
University of WashingtonNational Center for Complementary and Integrative Health (NCCIH)WithdrawnUpper Respiratory Infections
Clinical Trials on Hyland's Cold 'n Cough 4 Kids
-
University of WashingtonStandard Homeopathic CompanyCompleted